Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Soliton Inc (SOLY)

Soliton Inc (SOLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 189,808
  • Shares Outstanding, K 16,932
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,310 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 23.81

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.85 +14.62%
on 11/07/19
12.12 -6.88%
on 11/26/19
+0.64 (+6.01%)
since 11/06/19
3-Month
9.85 +14.62%
on 11/07/19
15.50 -27.16%
on 10/22/19
-1.84 (-14.01%)
since 09/06/19

Most Recent Stories

More News
Soliton Initiates Significant Step Towards Commercialization

Medical device innovation company Soliton, Inc. (Nasdaq: SOLY) today announced that it has engaged Tailfin, an Atlanta based brand and marketing firm, to help develop brand strategy and marketing and sales...

SOLY : 11.32 (+0.98%)
Soliton and Emphysys Enter Into a 3-year Development Agreement

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 11.32 (+0.98%)
Soliton Announces First Follow-up Visit Conducted in the Pivotal Cellulite Clinical Trial

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 11.32 (+0.98%)
Soliton Completes Treatment of All Patients in Pivotal Cellulite Trial

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 11.32 (+0.98%)
Soliton's Recent Positive Data Increases Potential Fibrotic Indications

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 11.32 (+0.98%)
Soliton Announces Positive Interim Clinical Trial Results with 27% Average Reduction in Scar Volume From Single Non-Invasive Treatment

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 11.32 (+0.98%)
Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 11.32 (+0.98%)
Soliton's FDA Cleared RAP Device is Granted Two Additional Key Patents

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical technology company that has developed a new acoustic shockwave device, today announced that the Taiwan Intellectual Property Office...

SOLY : 11.32 (+0.98%)
Soliton Announces $6.25 Million Private Placement

Soliton, Inc. (NASDAQ: SOLY), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"),...

SOLY : 11.32 (+0.98%)
Biotech Brief: U.S. Medical Technology Market Projected To Exceed $200 Billion By 2023

Medical device manufacturing remains a strong market, driven by technological developments, an aging population, and increases in chronic and lifestyle diseases - trends that expand healthcare spending....

MHMNF : 54.5000 (unch)
SOLY : 11.32 (+0.98%)
AKCA : 17.80 (+1.08%)
LVGO : 27.73 (+3.28%)
PFNX : 10.71 (+0.85%)
GILD : 67.14 (+1.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade SOLY with:

Business Summary

Soliton Inc. is a medical device company. Its commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos. Soliton Inc. is based in Houston, Texas.

See More

Key Turning Points

2nd Resistance Point 12.00
1st Resistance Point 11.61
Last Price 11.32
1st Support Level 10.71
2nd Support Level 10.20

See More

52-Week High 29.00
Fibonacci 61.8% 19.50
Fibonacci 50% 16.56
Fibonacci 38.2% 13.62
Last Price 11.32
52-Week Low 4.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar